The U.S. handed over a Chinese fugitive wanted for drug crimes, a rare move breaking a years-long standoff in law enforcement cooperation between the two powers.
This repatriation is seen as a major U.S. concession driven by the domestic fentanyl crisis, aimed at securing Beijing's help in stopping the flow of precursor chemicals.
The action diverges from the policies of many Western allies who refuse repatriations to China over human rights concerns, highlighting the unique pressure on Washington.
While Beijing gains a propaganda victory, the U.S. faces risks, including criticism over human rights and the possibility that China may not reciprocate with meaningful action on fentanyl.

Atlas AI
The United States has recently transferred a wanted individual into the custody of Chinese authorities in a low-profile handover that China publicly disclosed. China’s Xinhua state news agency identified the suspect only as surnamed Han and said the person was wanted for alleged drug smuggling and trafficking. The transfer involved U.S. Immigration and Customs Enforcement (ICE) and is described as the first publicly acknowledged handover of its kind in years.
S. side did not make the public announcement. S. concerns about China’s judicial system, including the use of the death penalty for drug crimes. S. officials have also cited worries that China has pursued political dissidents under the banner of anti-corruption efforts, factors that have contributed to Washington rejecting similar requests for years.
US-China Fugitive Handover Signals Potential Warming in Bilateral Law Enforcement Cooperation
The rare and publicly confirmed handover of a Chinese fugitive by the US to China, particularly amidst ongoing discussions about fentanyl cooperation, indicates a potential, albeit cautious, shift towards increased bilateral law enforcement engagement. This development is significant as such transfers have been halted for years due to US concerns regarding China's judicial system.
The handover comes against a backdrop of earlier, more routine cooperation that later deteriorated. After China’s entry into the global economic system, the U.S.-China Joint Liaison Group on Law Enforcement Cooperation (JLG), established in 1997, provided a channel for work on issues including intellectual property theft and counter-terrorism. Over the last decade, that practical collaboration weakened, and mutual trust was further strained by U.S. indictments against alleged Chinese agents.
S. imposed sanctions on Chinese entities, including the Ministry of Public Security’s Institute of Forensic Science, in response to human rights abuses in Xinjiang. Beijing responded by formally suspending most counternarcotics cooperation and made lifting the sanctions a condition for resuming talks. S. domestic pressure to address an overdose crisis linked to fentanyl, including the flow of Chinese-made precursor chemicals to Mexican drug cartels.
S. officials have treated fentanyl cooperation as a priority discussed by President Biden and President Xi Jinping at the 2023 APEC summit. S. agencies such as the Drug Enforcement Administration (DEA) and by diplomats at the State Department. S. Congress have criticized such moves as concessions that could undercut due process and human rights, pointing to China’s conviction rate exceeding 99% and warning about risks of torture or execution without a fair trial.
China, for its part, has portrayed the handover as evidence that its pursuit of fugitives can succeed internationally and as a message that other countries do not provide permanent refuge. The broader stakes remain uncertain: the U.S. is seeking practical cooperation to curb synthetic opioid deaths, described as exceeding 75,000 lives annually, while the risk cited by analysts is that Beijing could interpret the step as leverage to seek additional concessions in exchange for limited action.


